ArticleArchives of toxicology2025
Temporal analyses of germ cell mutations using the MutaMouse model support the recommended design in OECD test guideline 488.
Article in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Organisation for Economic Co-operation and Development test guideline (TG) 488 uses transgenic rodent models to assess in vivo mutagenesis. TG 488 recommends 28 consecutive days of exposure with sampling of germ cells from seminiferous tubules 28 days post-exposure (i.e., 28 + 28d). We analyzed mutant frequencies (MF) in male germ cells up to 70 days post-exposure to determine whether designs other than 28 + 28d are necessary for assessing germ cell mutagenicity. Adult MutaMouse males received various doses of benzo(a)pyrene (BaP), N-ethyl-N-nitrosourea (ENU), isopropyl methanesulfonate (iPMS), or procarbazine (PRC) alongside vehicle controls for 28 days orally. Germ cells were collected from seminiferous tubules at + 3d, + 28d, + 42d, or + 70d post-exposure and MF quantified using the lacZ assay. Significant increases in lacZ MF were observed for all four chemicals at 28 + 28d. No further increases occurred at later sampling times. There was no significant effect with BaP at 28 + 3d, and a significantly stronger response with ENU and BaP at 28 + 28d compared to 28 + 3d. PRC produced the strongest response at 28 + 3d, while there was no impact of different sampling times for iPMS. Both these chemicals significantly reduced testis weight at 28 + 3d and 28 + 28d. Finally, benchmark dose modeling generated overlapping confidence intervals among the four sampling times for ENU, iPMS, and PRC. However, for BaP, the confidence interval was significantly greater at 28 + 3d than at the other sampling times. These results support the use of the 28 + 28d design as the recommended experimental design for germ cells in TG 488 and that later sampling times are not necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.